MNV
Market News Video
MNV MNV 10 Stocks Crossing Below Book Value
MNV
MNV
MNV
MNV
MNV
MNV
MNV
Free Dividend Report - Top Ranked Stocks

Featured MNV Articles:

BIB's Underlying Holdings Imply 28% Gain Potential
Monday, November 11, 9:21 AM ET, by Market News Video Staff

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, ...

Peek Under The Hood: VTWO Has 11% Upside
Monday, December 16, 8:11 AM ET, by Market News Video Staff

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, ...

Analysts Anticipate VHT Will Reach $211
Monday, January 27, 8:46 AM ET, by Market News Video Staff

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, ...

Look Under The Hood: VTWV Has 21% Upside
Friday, February 28, 8:37 AM ET, by Market News Video Staff

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, ...

Sum Up The Parts: Russell 2000 Has 50% Upside
Wednesday, April 1, 9:17 AM ET, by Market News Video Staff

The financial media loves to get predictions from experts about where they think a given ...

RSI Alert: Five Prime Therapeutics (FPRX) Now Oversold

By Market News Video Staff, Wednesday, September 2, 11:58 AM ET
Play Video: Learn About The RSI


If the video does not load after a few moments, Upgrade to the Latest Flash Player.

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100. A stock is considered to be oversold if the RSI reading falls below 30.

In trading on Wednesday, shares of Five Prime Therapeutics, Inc (NASDAQ:FPRX) entered into oversold territory, hitting an RSI reading of 29.9, after changing hands as low as $4.18 per share. By comparison, the current RSI reading of the S&P 500 ETF (SPY) is 80.3. A bullish investor could look at FPRX's 29.9 RSI reading today as a sign that the recent heavy selling is in the process of exhausting itself, and begin to look for entry point opportunities on the buy side. The chart below shows the one year performance of FPRX shares:

Five Prime Therapeutics, Inc 1 Year Performance Chart

Looking at the chart above, FPRX's low point in its 52 week range is $1.75 per share, with $7.34 as the 52 week high point — that compares with a last trade of $4.22. Find out what 9 other oversold stocks you need to know about »


Special Offer: Receive our best dividend ideas directly to your inbox each afternoon with the Dividend Channel Premium Newsletter


This Article's Word Cloud:   About   Buffett   Channel   Dividend   FPRX   Find   Five   Index   Know   Legendary   Looking   Newsletter   Offer   Oversold   Premium   Prime   Receive   Relative   Should   Special   Start   Stocks   Strength   Therapeutics   Warren   Wednesday   about   above   advises   after   afternoon   analysis   below   chart   fearful   greedy   investor   look   others   oversold   point   raquo   reading   share   shares   stock   that   week   when   with
MNV
MNV
About Us - Advertise - Contact Us - Embedding Videos - Licensing Videos - Partners - mRSS / RSS Feed - Terms of Use - Privacy Policy
MNV
Home  |  Analyst News  Dividend Report  ETFs  Insider Report  Large Caps  Market Movers  Week Ahead Report  Weekly Market Wrap
MNV
MNV MNV Portfolio Channel Stock Market Definitions
MNV

RSI Alert: Five Prime Therapeutics (FPRX) Now Oversold | Market News Video | Copyright © 2008 - 2020, All Rights Reserved

Any ideas and opinions presented in all Market News Video clips are for informational and educational purposes only, and do not reflect the opinions of BNK Invest, Inc. or any of its affiliates, subsidiaries or partners. In no way should any content contained herein be interpreted to represent trading or investment advice. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. Read Full Disclaimer.